drugset / Trial / NCT04217304

SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial

NCT04217304 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

This study will assess the safety and feasibility of sonothrombolysis in the acute management of STEMI undergoing reperfusion therapy with systemic fibrinolysis as part of a pharmacoinvasive approach

Timeline

Start
2021-02-23
Primary completion
2026-01-19
Completion
2026-01-19

Outcome

Outcome not reported

Stopped: “Unlikely to demonstrate the intended benefit within the planned study design and statistical framework.”

Drugs

EvaluationDrugModalityDoseRoute
Background Definity Diagnostic / imaging agent 5 % Intravenous